ESCRS - Supplement: Premium IOL Solutions - Your way out of the Labyrinth ;
Supplements

Supplement: Premium IOL Solutions - Your way out of the Labyrinth

Supplement: Premium IOL Solutions - Your way out of the Labyrinth

One-stop premium IOL provider

In today's premium intraocular lens (IOL) market, the abundance of lens options and surgical techniques is overwhelming, evoking a sense of navigating through a labyrinth. A new paradigm has emerged: the art of selecting the right lens to match each patient's unique visual needs and expectations.

Medicontur has become a one-stop premium IOL provider for leading clinics around the world. This supplement showcases Medicontur's premium lead technologies and clinical insights by leading experts in the field of refractive surgery, showing a way out of this labyrinth.

Latest Articles
Overcoming Barriers to Presbyopic IOL Uptake

Improving technology, patient and doctor awareness, and reimbursement are keys.

Read more...

Battling Bias in Science

Hidden biases in science impact careers and patient care.

Read more...

Training in the Digital Era

AI-powered, cloud-based system can effectively improve traineeship, save time, and increase performance.

Read more...

Treating Myopia, Inside and Outside

Lifestyle changes and ophthalmic interventions play a role in treating paediatric myopia.

Read more...

The Promises and Pitfalls of AI

While AI shows potential in healthcare, experts agree it requires bias mitigation and human oversight.

Read more...

Visual Rehabilitation for Keratoconus

Concepts regarding best techniques shift based on learnings from longer follow-up.

Read more...

Discovering Prodygy and Nirvana

New gene-agnostic treatments for inheritable retinal disease.

Read more...

Cataract Surgery in Eyes with Corneal Disease

Applying information from preoperative diagnostics guides surgical planning.

Read more...

Supplement: Integrating Presbyopia-Correction into the Everyday Cataract Practice

Read more...

ESCRS Research Projects Make a Difference

EPICAT study continues tradition of practice-changing clinical studies.

Read more...